MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Spectrum of Movement Disorders in Kazakhstan: Five Years of Insights from Kazakhstan’s First Movement Disorder Center

    ZH. Myrzayev, CH. Shashkin, G. Seidakhmetova, B. Abdenov, R. Kaiyrzhanov (Almaty, Kazakhstan)

    Objective: To describe the spectrum, demographics, and trends of movement disorders patients seen at the first movement disorder (MD) center in Kazakhstan over five years.To…
  • 2024 International Congress

    Motor and Non-Motor Characteristics of Parkinson’s Disease in a Prevalent Population in Tanzania

    R. Morton, O. Williams, J. Josephat, M. Dekker, W. Howlett, E. Assey, N. Fothergill-Misbah, C. Dotchin, S. Urasa, R. Walker (North Shields, United Kingdom)

    Objective: To determine the features and characteristics of people with Parkinson’s (PwP) identified within a door-to-door prevalence study in Hai District, Tanzania. Background: There is an…
  • 2024 International Congress

    Phenomenology of Functional Movement Disorders in Children

    A. Cherian, D. Kalikavil Puthanveedu (Thiruvananthapuram, India)

    Objective: To study the phenomenology of Functional Movement Disorders (FMD) in children. Background: Data on FMD in children is sparse Method: The study included 13…
  • 2024 International Congress

    Clinical and epidemiological profile of Parkinson’s disease in India

    A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma (Kochi, India)

    Objective: To study the clinical profile and risk factors of Parkinson’s disease (PD) in India. Background: The current knowledge of clinical and epidemiological profile of…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • 2024 International Congress

    Changes in Parkinson’s Disease and Parkinsonian Syndromes A Comparative Retrospective Study in Kyrgyzstan

    S. Medetbekova, B. Nurbekova (Bishkek, Kyrgyzstan)

    Objective: This study compares Parkinson's disease (PD) and parkinsonian syndromes (PS) in patients at a Kyrgyzstan university hospital. It analyzes data from 2016-2017 [1] and…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • 2024 International Congress

    Uncovering Non-Motor Subtypes in Parkinson’s Disease through Machine Learning

    G. Pinilla-Monsalve, Y. Song, A. Young, A. Hanganu, O. Monchi (Montreal, Canada)

    Objective: This study aims to uncover subtypes of Parkinson’s disease (PD) through unsupervised machine learning (ML), based on the predicted evolution of non-motor symptoms (NMS).…
  • 2024 International Congress

    V-ATPase subunit V1G1 overexpression conferred the mice neuroprotection during MPTP exposure

    YIM. Wang, Y. Li, Y. Xia, L. Kou, T. Wang (武汉市, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton ATPase subunit G (V1G1) in the degradation and…
  • « Previous Page
  • 1
  • …
  • 228
  • 229
  • 230
  • 231
  • 232
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley